F.D.A. Allows New Remedy for Arthritis
Saturday, April 25, 2009 - 01:00
in Mathematics & Economics
The new drug is a follow-up to Remicade, which is marketed in the United States by Johnson & Johnson and in Europe and in other countries by the Schering-Plough Corporation.
Read the whole article on NY Times Health
More from NY Times Health
Related
- Biosensors DES demonstrates equivalent safety and efficacy to industry leading DESTue, 2 Sep 2008, 14:07:49 EDT
- Data on investigational drug TMC207 for MDR-TB published in New England Journal of MedicineWed, 3 Jun 2009, 17:43:51 EDT
- Global seed banking milestone celebrated by wildflower center, 122 other organizationsFri, 16 Oct 2009, 10:26:33 EDT
- New therapy for heart failureThu, 16 Oct 2008, 9:02:20 EDT
- Cell-coated stent as effective as drug-coated ones but needs less medsTue, 11 Nov 2008, 12:09:24 EST